BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11278155)

  • 21. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes.
    Dixon L
    Schizophr Res; 1999 Mar; 35 Suppl():S93-100. PubMed ID: 10190230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
    Thoma P; Daum I
    Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant relationship between lifetime alcohol use disorders and suicide attempts in an Australian schizophrenia sample.
    McLean D; Gladman B; Mowry B
    Aust N Z J Psychiatry; 2012 Feb; 46(2):132-40. PubMed ID: 22311529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comorbid substance use disorders in schizophrenia: a latent class approach.
    Kerner B
    Psychiatry Res; 2015 Feb; 225(3):395-401. PubMed ID: 25576367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conduct disorder, antisocial personality disorder and substance use disorders in schizophrenia and major affective disorders.
    Mueser KT; Rosenberg SD; Drake RE; Miles KM; Wolford G; Vidaver R; Carrieri K
    J Stud Alcohol; 1999 Mar; 60(2):278-84. PubMed ID: 10091967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups.
    Mueser KT; Yarnold PR; Rosenberg SD; Swett C; Miles KM; Hill D
    Schizophr Bull; 2000; 26(1):179-92. PubMed ID: 10755680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon.
    Karam EG; Yabroudi PF; Melhem NM
    Compr Psychiatry; 2002; 43(6):463-8. PubMed ID: 12439834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substance abuse in schizophrenia: a review.
    Buckley PF
    J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.
    Krystal JH; D'Souza DC; Gallinat J; Driesen N; Abi-Dargham A; Petrakis I; Heinz A; Pearlson G
    Neurotox Res; 2006 Dec; 10(3-4):235-52. PubMed ID: 17197373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term course of substance use disorders among patients with severe mental illness.
    Bartels SJ; Drake RE; Wallach MA
    Psychiatr Serv; 1995 Mar; 46(3):248-51. PubMed ID: 7796211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapse in schizophrenia: is there a relationship to substance abuse?
    Gupta S; Hendricks S; Kenkel AM; Bhatia SC; Haffke EA
    Schizophr Res; 1996 May; 20(1-2):153-6. PubMed ID: 8794503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Risk of homicide and major mental disorders: a critical review].
    Richard-Devantoy S; Olie JP; Gourevitch R
    Encephale; 2009 Dec; 35(6):521-30. PubMed ID: 20004282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy.
    Buckley P; Thompson P; Way L; Meltzer HY
    Am J Psychiatry; 1994 Mar; 151(3):385-9. PubMed ID: 8109646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remission and relapse of substance use disorders in schizophrenia. Results from a one-year prospective study.
    Cuffel BJ; Chase P
    J Nerv Ment Dis; 1994 Jun; 182(6):342-8. PubMed ID: 8201306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Schizophrenia and substance dependence].
    Uchtenhagen A
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):215-23. PubMed ID: 8658102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
    Clark RE; Xie H; Brunette MF
    J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder.
    Mueser KT; Yarnold PR; Bellack AS
    Acta Psychiatr Scand; 1992 Jan; 85(1):48-55. PubMed ID: 1546548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.